German agrochemical giant Bayer has proposed a $7.25bn settlement to resolve thousands of lawsuits claiming its Roundup weedkiller causes cancer. The settlement aims to address around 65,000 claims from plaintiffs who allege they developed non-Hodgkin lymphoma after using the product. Bayer will make annual payments for up to 21 years, but it does not admit liability. CEO Bill Anderson said: “Litigation uncertainty has plagued the company for years, and this settlement gives the company a road to closure.” The proposal requires court approval and a minimum number of plaintiffs to opt in.